Back to Agenda
Session 4: Concrete Actions among Individual Partners and Stakeholders to Prepare for the HTAR Implementation
Session Chair(s)
Dirk Van Den Steen
HTA Deputy Head of Unit
European Commission, Belgium
Niklas Hedberg, MPharm
HTACG Co-Chair & Chief Pharmacist
Dental and Pharmaceutical Benefits Agency, TLV, Sweden
The different stakeholders will share what they have been doing and what they are currently doing to prepare themselves to be ready by the time of the HTAR application (education, mobilizing resources, adapting processes and organisation). They will discuss how they can work together, while processes are simultaneously evolving as the key parts of the Pharmaceutical Strategy are being delivered.
Speaker(s)
National HTA Agencies’ Perspective
Niklas Hedberg, MPharm
Dental and Pharmaceutical Benefits Agency, TLV, Sweden
HTACG Co-Chair & Chief Pharmacist
National HTA Agencies’ Perspective
Anne Willemsen, MSc
ZIN - National Health Care Institute, Netherlands
Senior Project Manager, Joint Production Co-Lead Partner - Pharmaceuticals
EMA Perspective
Michael Berntgen, PhD
European Medicines Agency, Netherlands
Head of Scientific Evidence Generation
Industry Perspective
Alexander Natz, JD
European Confederation of Pharmaceutical Entrepreneurs, Belgium
Secretary General
Industry Perspective
Adam Parnaby
Bristol Myers Squibb, Belgium
Senior Director, Market Access Policy
Patient Perspective
Antonella Cardone
Cancer Patients Europe, Belgium
Director
Payer Perspective
Rasmus Syberg Hazelton, MSc
Amgros, Denmark
Senior Advisor International Affairs
Have an account?